Chinook shares down about 6%, paring steep loss after Muddy Waters reveals short position in drugmaker

[ad_1]

Business & FinanceHealth

Reuters was first to report that well known short seller Muddy Waters was taking a new short position on Tuesday, in pharmaceutical company, Chinook Therapeutics Inc <KDNY.O >. Chinook’s share prices, which fell as much 18% on Tuesday, dropped within minutes of Reuters reporting.

Market Impact

The stock was last down 6.77% at $21.815 a share. But immediately after Muddy Waters announced its short position, a bet the stock would decline, Chinook shares fell as low as $19.20, down 18% from the $23.40 close on Monday. Other healthcare stocks also fell.

Article Tags

Topics of Interest: Business & FinanceHealth

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Americas

Countries: United States

Win Types: Speed

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

[ad_2]

Source link

Related articles

Cigna explores shedding Medicare Advantage business 

[ad_1] DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.   Market […]

What are nitazenes? What to know about the drug that can be 10 times as potent as fentanyl

[ad_1] Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports Colorado law enforcement warning about opioid recently showing up in overdose toxicology reports 01:13 An overdose death in Colorado has been linked to a new formulation of nitazenes, a class of powerful opioid analgesics being increasingly seen in the illicit drug […]

Leave a Reply

Your email address will not be published. Required fields are marked *